EQ Trial Network focuses on optimizing clinical trials to better fit the SDoH (Social Determinants of Health Framework). While many clinical trials are designed for operational efficiency, they often overlook barriers related to insurance status, income, language access, transportation and community trust- factors that impact marginalized patient populations. We support clinical research efforts within the following cancer specialties: GI, GU, Breast, Thoracic, Bone Marrow Transplant, Myeloid Disorders, Multiple Myeloma, Neuro-Oncology, Pediatric, Gynecology-Oncology, Head and Neck, Melanoma, Phase 1.

We collaborate with Academic Medical Centers (AMCs), Pharmaceutical Sponsors, Digital Health start-ups, Clinical Research Organizations (CROs), local governments and patient advocacy groups-  just to name a few. Our work includes clinical trial protocol review, patient recruitment strategy and development along with culturally grounded community outreach.

We build local partnerships with Academic Medical Centers (AMCs), patient advocacy groups and non-profits. We collaborate with patient navigators and health care professionals to support the implementation of inclusive research language in clinical research.

Whether you’re an Academic Medical Center (AMC), Clinical Research Organization (CRO), pharmaceutical sponsor, a digital health start-up or a patient advocacy group, EQ Trial Network offers specialized consulting and advisory solutions. Please reach out through our Contact Us page to start the conversation!